These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7186499)

  • 1. The effect of iron-dextran on the biodistribution of technetium pyrophosphate.
    Choy D; Maddalena DJ; Murray IP
    Int J Nucl Med Biol; 1982; 9(4):277-82. PubMed ID: 7186499
    [No Abstract]   [Full Text] [Related]  

  • 2. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 99mTc bone scanning agents--IV. Chemical characterization of 99mTc(Sn)-pyrophosphate complexes.
    Kroesbergen J; Roozen AM; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(2):209-14. PubMed ID: 3366621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
    Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoradiographic comparison of 96Tc-pyrophosphate and 45Ca bone uptake.
    Le Pape A; Guillemart A
    Eur J Nucl Med; 1982; 7(3):127-9. PubMed ID: 7067714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of adjunctive drugs to alter uptake of 99mTc-Sn-pyrophosphate by myocardial lesions and bone.
    Carr EA; Carroll M; Montes M
    Life Sci; 1978 Apr 3-17; 22(13-15):1261-74. PubMed ID: 207941
    [No Abstract]   [Full Text] [Related]  

  • 7. Myocardial uptake of technetium-99m stannous pyrophosphate in experimental viral myopericarditis.
    Kadota K; Matsumori A; Kambara H; Kawai C
    J Nucl Med; 1979 Oct; 20(10):1047-50. PubMed ID: 231641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does cardioversion of atrial fibrillation result in myocardial damage?
    Metcalfe MJ; Smith F; Jennings K; Paterson N
    Br Med J (Clin Res Ed); 1988 May; 296(6633):1364. PubMed ID: 3134987
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of local heating on the uptake of 99m-technetium labeled pyrophosphate of tin in humans].
    Mortier G; Blockx P; CHappel R
    J Belge Rhumatol Med Phys; 1976; 31(5):256-60. PubMed ID: 1027749
    [No Abstract]   [Full Text] [Related]  

  • 10. Ligand-free, protein-bound technetium-99m iron-dextran enhancement of technetium pyrophosphate uptake in tumours.
    Pojer PM; Jakovljevic AC; Wise KN; Lichtenstein M
    Nucl Med Commun; 1985 Jun; 6(6):359-63. PubMed ID: 3037456
    [No Abstract]   [Full Text] [Related]  

  • 11. [Technetium-99m stannous pyrophosphate myocardial scintigraphy].
    Tada A; Bungyo H; Hisada K
    Rinsho Hoshasen; 1983 Feb; 28(2):345-6. PubMed ID: 6865056
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effective use of stannous pyrophosphate.
    Sands M; Owunwanne A
    J Nucl Med; 1981 Oct; 22(10):932. PubMed ID: 7288493
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatic uptake of 99Tc stannous pyrophosphate in experimental viral pancreatitis in mice.
    Matsumori A; Kadota K; Kawai C
    Eur J Nucl Med; 1981 Apr; 6(4):163-7. PubMed ID: 6260500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrophosphate scanning in early frostbite injury.
    Purdue GF; Lewis SA; Hunt JL
    Am Surg; 1983 Nov; 49(11):619-20. PubMed ID: 6638703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered biodistribution of Tc-99m HMDP on bone scintigraphy from recent intravenous iron therapy.
    Forauer AR; Grossman SJ; Joyce JM
    Clin Nucl Med; 1994 Sep; 19(9):817-8. PubMed ID: 7982320
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
    Anger K; Aigner S; Bühler M; Umbach I
    Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Count density method for sizing myocardial infarction with Tc-99m-stannous pyrophosphate myocardial scintigraphy].
    Kiriyama T; Kondo T; Watanabe Y; Kaneko K; Kato Y; Sakurai M; Kurokawa H; Hishida H; Mizuno Y; Ejiri K
    Kaku Igaku; 1985 Jan; 22(1):75-9. PubMed ID: 3999458
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of technetium-99m pyrophosphate and technetium-99m methylene diphosphonate with variable amounts of stannous chloride in the detection of acute myocardial infarction.
    Huckell VF; Lyster DM; Morrison RT; Cooper JA
    Clin Nucl Med; 1985 Jul; 10(7):455-62. PubMed ID: 4028596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic significance of electrocardiography and myocardial scintigraphy with 99m Tc-Sn-pyrophosphate and 99m Tc-Sn-phosphone in patients with stenocardia].
    Zudbinov IuI; Ponomareva AG; Sokolov OK
    Med Radiol (Mosk); 1986 Aug; 31(8):22-6. PubMed ID: 3091990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying effect of commercially available stannous pyrophosphate (PYRO-Sn) on the tissue affinity of 99mTc pertechnetate.
    Bałtrukiewicz Z; Przedlacki J; Dziuk E
    Eur J Nucl Med; 1980; 5(1):45-7. PubMed ID: 7379805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.